Your search returned the following 20 documents:

20. Accurate prediction of drug-exposure without using established drug-resistance mutations
    Alejandro Pironti, Nico Pfeifer, Rolf Kaiser, Hauke Walter, and Thomas Lengauer
    In: Antiviral Therapy, Berlin, Germany, 2014, A75 p.
    
19. Improved HIV-1 drug-exposure reconstruction with linear support vector machines
    Alejandro Pironti, Nico Pfeifer, Rolf Kaiser, Hauke Walter, and Thomas Lengauer
    In: Reviews in Antiviral Therapy & Infectious Diseases, Barcelona, Spain, 2014, 67 p.
    
18. Improved therapy-success prediction with GSS estimated from clinical HIV-1 sequences
    Alejandro Pironti, Nico Pfeifer, Rolf Kaiser, Hauke Walter, and Thomas Lengauer
    In: Abstract Supplement of the HIV Drug Therapy Glasgow Congress 2014, Glasgow, UK, 2014, 155 p.
    
17. HIV-GRADE: A Publicly Available, Rules-Based Drug Resistance Interpretation Algorithm Integrating Bioinformatic Knowledge
    Martin Obermeier, Alejandro Pironti, Thomas Berg, Patrick Braun, Martin Däumer, Josef Eberle, Robert Ehret, Rolf Kaiser, Niels Kleinkauf, Klaus Korn, Claudia Kücherer, Harm Müller, Christian Noah, Martin Stürmer, Alexander Thielen, Eva Wolf, and Hauke Walter
    Intervirology 55: 102-107, 2012
    
16. Only Slight Impact of Predicted Replicative Capacity for Therapy Response Prediction
    Hendrik Weisser, André Altmann, Saleta Sierra, Francesca Incardona, Daniel Struck, Anders Sönnerborg, Rolf Kaiser, Maurizio Zazzi, Monika Tschochner, Hauke Walter, and Thomas Lengauer
    PLoSOne 5 (2): e9044,1-e9044,10, 2010
    
15. Performance of genotypic coreceptor measurement using geno2pheno[coreceptor] in B- and non-B HIV subtypes in a large cohort of therapy-experienced patients in Germany
    Alexander Thielen, Nadine Sichtig, Patrick Braun, Martin Däumer, Hauke Walter, Christian Noah, Eva Wolf, Harm Müller, Martin Stürmer, Thomas Lengauer, Rolf Kaiser, and Martin Obermeier
    In: Reviews in Antiviral Therapy, Stockholm, Sweden, 2009, 99-99
    
14. Determination of HIV-1 co-receptor usage in German patients – comparison of genotypic methods with the TROFILE® phenotypic assay
    Martin Obermeier, Thomas Berg, Nadine Sichtig, Patrick Braun, Martin Däumer, Hauke Walter, Christian Noah, Eva Wolf, Harm Müller, Martin Stürmer, Alexander Thielen, and Rolf Kaiser
    In: Abstracts of the Ninth International Congress on Drug Therapy in HIV Infection, Glasgow, UK, 2008, 123 p.
    
13. Determination of HIV-1 coreceptor usage in German patients - comparison of genotypic methods with the TROFILE phenotypic assay
    Martin Obermeier, Nadine Sichtig, Patrick Braun, Martin Däumer, Hauke Walter, Christian Noah, Eva Wolf, Harm Müller, Martin Stürmer, Rolf Kaiser, and Alexander Thielen
    In: Antiviral Therapy, Sitges, Spain, 2008, A112 p.
    
12. Validation of geno2pheno and THEO on a large independent clinical dataset
    Andre Altmann, Martin Däumer, Tobias Sing, Niko Beerenwinkel, Hauke Walter, Rolf Kaiser, and Thomas Lengauer
    In: Proceedings of the 5th European HIV Drug Resistance Workshop, Cascais, Portugal, 2007
    
11. Characterization of novel HIV Drug Resistance Mutations using clustering, multidimensional scaling and SVM-based feature ranking
    Tobias Sing, Valentina Svicher, Niko Beerenwinkel, Francesca Ceccherini-Silberstein, Martin Däumer, Rolf Kaiser, Hauke Walter, Klaus Korn, Daniel Hoffmann, Mark Oette, Jürgen K. Rockstroh, Gerd Fätkenheuer, Carlo-Federico Perno, and Thomas Lengauer
    In: Knowledge Discovery in Databases: PKDD 2005., Porto, Portugal, 2005, 285-296
    
10. Computational methods for the design of effective therapies against drug resistant HIV strains
    Niko Beerenwinkel, Tobias Sing, Thomas Lengauer, Jörg Rahnenführer, Kirsten Roomp, Igor Savenkov, Roman Fischer, Daniel Hoffmann, Joachim Selbig, Klaus Korn, Hauke Walter, Thomas Berg, Patrick Braun, Gerd Fätkenheuer, Mark Oette, Jürgen Rockstroh, Bernd Kupfer, Rolf Kaiser, and Martin Däumer
    Bioinformatics 21 (21): 3943-3950, 2005
    
9. Estimating effective drug combinations against drug-resistant mutants from genotypes
   Niko Beerenwinkel, Martin Däumer, Rolf Kaiser, Hauke Walter, Klaus Korn, Daniel Hoffmann, Joachim Selbig, and Thomas Lengauer
   In: Proceedings of the 1st European HIV Drug Resistamce Workshop, Luxembourg, March 6-8, 2003, 2003, 18-18
   
8. Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes
   Niko Beerenwinkel, Martin Däumer, Mark Oette, Klaus Korn, Daniel Hoffmann, Rolf Kaiser, Thomas Lengauer, Joachim Selbig, and Hauke Walter
   Nucleic Acids Research 31 (13): 3850-3855, 2003
   
7. Methods for optimizing antiviral combination therapies
   Niko Beerenwinkel, Thomas Lengauer, Martin Däumer, Rolf Kaiser, Hauke Walter, Klaus Korn, Daniel Hoffmann, and Joachim Selbig
   Bioinformatics 19 (Supplement): i16-i25, 2003
   
6. Tenofovir resistance and resensitization
   Katharina Wolf, Hauke Walter, Niko Beerenwinkel, Wilco Keulen, Rolf Kaiser, Daniel Hoffmann, Thomas Lengauer, Joachim Selbig, Anne-Mieke Vandamme, Klaus Korn, and Barbara Schmidt
   Antimicrobial Agents and Chemotherapy 47 (11): 3478-3484, 2003
   
5. Diversity and complexity of HIV-1drug resistance: A bioinformatics approach to predicting phenotype from genotype
   Niko Beerenwinkel, Barbara Schmidt, Hauke Walter, Rolf Kaiser, Thomas Lengauer, Daniel Hoffmann, Klaus Korn, and Joachim Selbig
   Proceedings of the National Academy of Sciences 99 (12): 8271-8276, 2002
   
4. Geno2pheno is predictive of short-term virological response
   Niko Beerenwinkel, Thomas Lengauer, Martin Däumer, S. Sierra, Barbara Schmidt, Hauke Walter, Klaus Korn, Mark Oette, Gerd Fätkenheuer, J. Rockstroh, Daniel Hoffmann, Rolf Kaiser, and Joachim Selbig
   In: Proceedings from the 5th International Workshop on HIV Drug Resistance & Treatment Strategies, Scotsdale, Arizona, 2002, 74-74, paper no. 89.
   
3. Quantitative phenotype prediction by support vector machines
   Niko Beerenwinkel, Thomas Lengauer, Barbara Schmidt, Hauke Walter, Rolf Kaiser, Daniel Hoffmann, Klaus Korn, and Joachim Selbig
   In: Proceedings from the 5th International Workshop on HIV Drug resistance & Treatment Strategies, Scotsdale, Arizona, 2002, 97 p.
   
2. Geno2pheno: A system for the interpretation of genotypic HIV Drug resistance tests
   Niko Beerenwinkel, Barbara Schmidt, Hauke Walter, Rolf Kaiser, Thomas Lengauer, Daniel Hoffmann, Klaus Korn, and Joachim Selbig
   IEEE Intelligent Systems 16 (6): 35-41, 2001
   
1. Neue Wege zur Optimierung von Anti-HIV Therapien
   Niko Beerenwinkel, Martin Däumer, Daniel Hoffmann, Rolf Kaiser, Klaus Korn, Thomas Lengauer, Barbara Schmidt, Hauke Walter, and Joachim Selbig
   BIOforum 24 (12): 912-914, 2001